SCOPUS 정보 검색 플랫폼

Journal of the Royal Society of Medicine

Volumn 94, Issue 3, 2001, Pages 119-123

BCG immunotherapy for superficial bladder cancer

(2) Lockyer, C R W a Gillatt, D A a

a SOUTHMEAD HOSPITAL (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; DOXORUBICIN; EPIRUBICIN; MITOMYCIN C; THIOTEPA;

ALLERGY; BLADDER CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER PREVENTION; CANCER RECURRENCE; CLINICAL TRIAL; CYSTITIS; CYSTOSCOPY; DRUG EFFICACY; DRUG MECHANISM; DYSURIA; FEVER; HEMATURIA; HUMAN; OUTCOMES RESEARCH; PROSTATITIS; REVIEW; SUPERFICIAL CANCER;

EID: 0035057055 PISSN: 01410768 EISSN: None Source Type: Journal
DOI: 10.1177/014107680109400305 Document Type: Review

Times cited : (37)

References (35)

1
- 0024382042
- Prognostic factors for recurrence and follow up policies in the treatment of superficial bladder cancer: Report from the British Medical Research Council subgroup on superficial bladder cancer
- (1989) J Urol , vol.142 , pp. 284-288
- Parmar, M.¹ Freedman, L.² Hargreave, T.³ Tolley, D.⁴

2
- 0023186847
- Prognosis of bladder cancer
- (1987) Eur Urol , vol.13 , pp. 145-149
- Pagano, F.¹ Garbeglio, A.² Milani, C.³ Bassi, P.⁴ Pegoraro, V.⁵

3
- 77957182488
- Cancer and tuberculosis
- (1929) Am J Hyg , vol.9 , pp. 97-159
- Pearl, R.¹

4
- 0014664421
- Active immunotherapy for acute lymphoblastic leukaemia
- (1969) Lancet , vol.1 , pp. 697-699
- Mathé, G.¹ Amiel, J.L.² Schwarzenberg, L.³

5
- 0013878104
- Extracutaneous delayed hypersensitivity, particularly in guinea pig bladder
- (1966) Immunology , vol.10 , pp. 127-136
- Coe, J.E.¹ Feldman, J.D.²

6
- 0017130525
- Intracavitary BCG in the treatment of superficial bladder tumours
- (1976) J Urol , vol.116 , pp. 180-183
- Morales, A.¹ Eidinger, D.² Bruce, A.W.³

7
- 0018959101
- BCG immunotherapy of superficial bladder cancer
- (1980) J Urol , vol.124 , pp. 38-40
- Lamm, D.L.¹ Thor, D.E.² Harris, S.C.³ Reyna, J.A.⁴ Stogdill, V.D.⁵ Rasdwin, H.M.⁶

8
- 0025366329
- The response of patients with superfidal bladder cancer to a second course of intravesical BCG
- (1990) J Urol , vol.143 , pp. 710-713
- Bretton, P.R.¹ Herr, H.W.² Kimmel, M.³

9
- 0023099858
- Risks and benefits of repeated courses of intravesical BCG for superficial bladder cancer
- (1987) J Urol , vol.137 , pp. 220-224
- Catalona, W.J.¹ Hudson, M.A.² Gillen, D.P.³

10
- 0023193318
- Requirement of a thymus dependent immune response for BCG mediated antitumour activity
- (1987) J Urol , vol.137 , pp. 155-158
- Ratliff, T.L.¹ Gillen, D.² Catalona, W.J.³

11
- 0023840266
- Role of fibronectin in intravesical BCG therapy for superficial bladder cancer
- (1988) J Urol , vol.139 , pp. 410-414
- Ratliff, T.L.¹ Kavoussi, L.R.² Catalona, W.J.³

12
- 0025823180
- Internalization of BCG by bladder tumour cells
- (1991) J Urol , vol.145 , pp. 1316-1324
- Beich, M.J.¹ Carroll, S.² Ratliff, T.L.³

13
- 0027179385
- T-cell subsets required for intravesical BCG immunotherapy for bladder cancer
- (1993) J Urol , vol.150 , pp. 1018-1023
- Ratliff, T.L.¹ Ritchey, J.K.² Yuan, J.J.³ Andrilow, G.L.⁴ Catalona, W.J.⁵

14
- 0028915845
- Changes in urinary cytokines and soluble intercellular adhesion molecule-1 (ICAM-1) in bladder cancer patients after BCG immunotherapy
- (1995) Clin Exp Immunol , vol.99 , pp. 369-375
- Jackson, A.M.¹ Alexandroff, A.B.² Kelly, R.W.³

15
- 0028251192
- Understanding the most successful immunotherapy for cancer
- (1994) Immunologist , vol.2 , pp. 208-215
- Jackson, A.M.¹ James, K.²

16
- 0026703187
- Murine bladder carcinoma cells present antigen to BCG specific CD4 T-cells
- (1992) Cancer Res , vol.52 , pp. 4286-4290
- Lattime, E.C.¹ Gomella, L.G.² McCue, P.A.³

17
- 0028870491
- BCG treatment of existing papillary bladder cancer in situ of the bladder
- (1995) Cancer , vol.75 , pp. 552-559
- Akaza, H.¹ Hinotsu, S.² Aso, Y.³

18
- 0026665513
- Outcome in carcinoma in situ of bladder treated with intravesical BCG
- (1992) Br J UroI , vol.70 , pp. 271-275
- Harland, S.J.¹ Charing, C.R.² Highman, W.³ Parkinson, M.C.⁴ Riddle, P.R.⁵

19
- 0028944354
- Analysis of early failures after intravesical instillation therapy with BCG for carcinoma in situ of the bladder
- (1995) Br J Urol , vol.75 , pp. 180-184
- Merz, V.W.¹ Marth, D.² Kraft, R.³ Ackermann, D.K.⁴ Zingg, E.J.⁵ Studer, U.E.⁶

20
- 0026725003
- Long term results of intravesical therapy for superficial bladder cancer
- (1992) Urol Clin N Am , vol.19 , pp. 573-580
- Lamm, D.L.¹

21
- 0030213699
- A randomized prospective study comparing long term intravesical instillations of MMC and BCG in patients with superficial bladder cancer
- (1996) J Urol , vol.156 , pp. 372-376
- Lundholm, C.¹ Norten, B.J.² Eckman, P.³

22
- 0001650032
- SWOG 8795. A randomized comparison of BCG and MMC prophylaxis in stage Ta & T1 transitional cell carcinoma of the bladder
- (1993) J Urol , vol.149
- Lamm, D.L.¹ Crawford, E.D.² Blumenstain, B.³

23
- 0002058825
- Prospective randomized study of adjuvant therapy after complete resection of superficial bladder cancer: MMC vs. BCG vs. TUR alone
- Edinburgh: Churchill Livingstone
- (1990) Immunotherapy of Urological Tumours , pp. 27-36
- Rubben, H.¹ Graf-Dobberstein, C.² Ostwald, R.³

24
- 0028909213
- A randomized study of intravesical MMC, BCG-TICE and BCG-R1VM treatment in pTa and pT1 papillary carcinoma and carcinoma in situ of the bladder
- (1995) J Urol , vol.153 , pp. 929-933
- Vegt, P.D.J.¹ Witjes, A.² Witjes, W.P.J.³

25
- 0024164585
- BCG therapy alters the progression of superficial bladder cancer
- (1988) J Clin Oncol , vol.6 , pp. 1450-1455
- Herr, H.W.¹ Laudone, V.P.² Badalament, R.A.³

26
- 0026004545
- A randomized trial of intravesical doxorubicin and immunotherapy with BCG of transitional cell carcinoma of the bladder
- (1991) N Engl J Med , vol.325 , pp. 1205-1209
- Lamm, D.L.¹ Blumenstein, B.A.² Crawford, E.D.³

27
- 0026040122
- A low dose BCG regimen in superficial bladder cancer: Is it effective?
- (1991) J Urol , vol.146 , pp. 32
- Pagano, F.¹ Bassi, P.² Milani, C.³

28
- 0029053868
- Intravesical bacillus Calmette-Guérin therapy prevents tumor progression and death from superficial bladder cancer: Ten year follow-up of a prospective randomized trial
- (1995) J Clin Oncol , vol.13 , pp. 1404-1408
- Herr, H.W.¹ Schwalb, D.M.² Zhang, Z.F.³

29
- 0030914050
- The treated natural history of high risk superficial bladder cancer: 15 year outcome
- (1997) J Urol , vol.158 , pp. 62-67
- Cookson, M.S.¹ Herr, H.W.² Zhang, Z.F.³

30
- 0025272128
- BCG versus doxorubicin versus thiotepa: A randomized prospective study in 202 patients with superficial bladder cancer
- (1990) J Urol , vol.143 , pp. 502-506
- Martinez Pineiro, J.A.¹ Jimenez Leon, J.² Martinez-Pineiro, L.³

31
- 0000936876
- Final report on a randontized multicentre trial on adjuvant therapy in superficial bladder cancer. TUR only vs. TUR & MMC vs. TUR & BCG
- abstract
- (1996) J Urol , vol.155
- Krege, S.¹ Otto, T.² Rubben, H.³ Meyer, R.⁴ Gianni, G.⁵

32
- 0034105381
- Maintenance bacillus Calmette-Guérin immunotherapy for recurrent Ta, T1 and carcinoma in situ transitional cell carcinoma of the bladder: A randomized Southwest Oncology Group study
- (2000) J Urol , vol.163 , pp. 1124-1129
- Lamm, D.L.¹ Blumenstein, B.A.² Crissman, J.D.³

33
- 0033977622
- BCG intravesical instillations: Recommendations for side-effects management
- (2000) Eur Urol , vol.37 , Issue.SUPPL. 1 , pp. 33-36
- Rischmann, P.¹ Desgrandchamps, F.² Lalavaud, B.³ Chopin, D.K.⁴

34
- 0345008947
- Interference of modern antibacterials with Bacillus Calmette-Guérin viability
- (1999) J Urol , vol.162 , pp. 1959-1962
- Durek, C.¹ Rusch-Gerdes, S.² Jocham, D.³ Bohle, A.⁴

35
- 0000294491
- Complications of bacillus Calmette-Guérin immunotherapy: Review of 2602 patients and comparison of chemotherapy complications
- (1989) EORTC Genitourinary Group Monogr , vol.6 , pp. 335-355
- Lamm, D.L.¹ Steg, A.² Boccon-Gibod, L.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.